Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial

F Moniche, A Gonzalez, JR Gonzalez-Marcos… - Stroke, 2012 - Am Heart Assoc
Background and Purpose— Bone marrow mononuclear cell (BM-MNC) intra-arterial
transplantation improves recovery in experimental models of ischemic stroke. We aimed to assess …

Break in the stroke chain of survival due to COVID-19

…, S Pérez-Sánchez, I Escudero-Martínez, F Moniche… - Stroke, 2020 - Am Heart Assoc
Background and Purpose: Emergency measures to treat patients with coronavirus disease
2019 (COVID-19) and contain the outbreak is the main priority in each of our hospitals; …

Combination of thrombolysis and statins in acute stroke is safe: results of the STARS randomized trial (stroke treatment with acute reperfusion and simvastatin)

…, D Giralt, B Vives-Pastor, A De Arce, F Moniche… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— The STARS trial (Stroke Treatment With Acute Reperfusion and
Simvastatin) was conducted to demonstrate the efficacy and safety of simvastatin treatment …

Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment: a phase 1/2 randomized clinical trial

…, PC Portela, J Masjuán, F Moniche… - JAMA …, 2023 - jamanetwork.com
Importance ApTOLL is a TLR4 antagonist with proven preclinical neuroprotective effect and
a safe profile in healthy volunteers. Objective To assess the safety and efficacy of ApTOLL in …

Early neurological change after ischemic stroke is associated with 90-day outcome

…, E Muiño, J Cárcel-Márquez, F Moniche… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Large-scale observational studies of acute ischemic stroke (AIS)
promise to reveal mechanisms underlying cerebral ischemia. However, meaningful …

Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised …

F Moniche, JA Cabezas-Rodriguez, R Valverde… - The Lancet …, 2023 - thelancet.com
Background Pilot clinical trials have shown the safety of intra-arterial bone marrow
mononuclear cells (BMMNCs) in stroke. However, the efficacy of different doses of intra-arterial …

Predictors of restenosis following carotid angioplasty and stenting

E Zapata-Arriaza, F Moniche, A González… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— Restenosis after carotid angioplasty (with or without stent) is
associated with increased rate of stroke and death. Our aim was to determine risk and …

Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry

J Pagola, J Juega, J Francisco-Pascual, A Moya… - International Journal of …, 2018 - Elsevier
Background We describe the feasibility of monitoring with a Textile Wearable Holter (TWH)
in patients included in Crypto AF registry. Methods We monitored cryptogenic stroke patients …

Increasing dose of autologous bone marrow mononuclear cells transplantation is related to stroke outcome: results from a pooled analysis of two clinical trials

F Moniche, PH Rosado-de-Castro… - Stem Cells …, 2016 - Wiley Online Library
Background and Purpose. BM‐MNC transplantation improves recovery in experimental models
of ischemic stroke. Clinical trials are ongoing to test efficacy in stroke patients. However, …

External validation of the ISAN, A2DS2, and AIS-APS scores for predicting stroke-associated pneumonia

…, MÁ Gamero, Á Quesada, DV De Francisco… - Journal of Stroke and …, 2018 - Elsevier
Background The Prestroke Independence, Sex, Age, National Institutes of Health Stroke
Scale (ISAN), Age, Atrial Fibrillation, Dysphagia, male sex, and National Institutes of Health …